- Report
- April 2025
- 200 Pages
Global
From €4113EUR$4,490USD£3,496GBP
Bells Palsy is a form of facial paralysis that affects the muscles on one side of the face. It is caused by damage to the facial nerve, which controls the muscles in the face. Treatment for Bells Palsy typically involves medications that can reduce inflammation and improve nerve function. These medications are part of the Central Nervous System (CNS) Drugs market.
CNS Drugs are used to treat a variety of neurological conditions, including epilepsy, Parkinson's disease, multiple sclerosis, and Alzheimer's disease. They are also used to treat psychiatric disorders, such as depression and anxiety. The CNS Drugs market is highly competitive, with a wide range of products available.
Some of the major players in the Bells Palsy Drug market include Pfizer, GlaxoSmithKline, Merck, Novartis, and Sanofi. These companies produce a variety of medications for the treatment of Bells Palsy, including corticosteroids, antivirals, and anticonvulsants. Other companies in the market include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more